PharmaShots | Incisive News in 3 Shots

Subscribe Now

CGRP Receptor Antagonist

Allergan Announces Completion of UBR-MD-04 & 3110-105-002 Study for Treatment of Migrane

Allergan Announces Completion of UBR-MD-04 & 3110-105-002 Study for Treatment of Migrane

October 18, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us